Related Experiment Videos
Neoadjuvant therapy for gastric cancer
Manpreet K Chadha1, Boris W Kuvshinoff, Milind M Javle
1Department of Medicine, State University of New York, University at Buffalo, Erie County Medical Center, USA.
Oncology (Williston Park, N.Y.)
|November 1, 2005
Summary
Neoadjuvant therapy shows promise for gastric cancer, potentially improving outcomes beyond current standard treatments. Further research into targeted agents and biologic changes is recommended for refining this investigational approach.
Area of Science:
- Oncology
- Surgical Oncology
- Gastroenterology
Background:
- Gastric cancer is a significant global health problem, often diagnosed at advanced stages with limited treatment efficacy.
- Current treatments, including surgery and adjuvant therapy, offer modest survival benefits and are associated with significant morbidity.
- Neoadjuvant therapy, while standard for other upper gastrointestinal cancers, remains investigational for gastric cancer.
Purpose of the Study:
- To review the current literature on neoadjuvant therapy for gastric cancer.
- To assess the feasibility and potential benefits of neoadjuvant strategies.
- To identify future research directions for optimizing neoadjuvant treatment.
Main Methods:
- Literature review of phase II studies on neoadjuvant therapy for gastric cancer.
- Analysis of existing data on feasibility and outcomes.
- Exploration of novel targeted agents and tumor biology assessment.
Main Results:
- Small phase II studies suggest neoadjuvant therapy is feasible for gastric cancer.
- Neoadjuvant approaches may offer improved outcomes compared to current standards.
- Incorporating targeted agents and studying tumor response could refine treatment efficacy.
Conclusions:
- Neoadjuvant therapy represents a promising, albeit investigational, approach for gastric cancer management.
- Further research is warranted to explore targeted agents and understand tumor biology in neoadjuvant settings.
- Refined neoadjuvant strategies hold potential for improving survival and quality of life in gastric cancer patients.